Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renvela in Diabetics With Nephropathy
NCT01493050Phase 2Completed
- Start
- Feb 2012
- Primary completion
- Dec 2013
- Countries
- 1
01
Overview
A Phase 2 trial of sevelamer carbonate in diabetic nephropathy (DN). Started Feb 2012; status: completed.
02
Drugs
sevelamer carbonate
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT01493050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01493050.